(Q43253820)

17 November 2017

The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy (English)

1 reference

17 November 2017

1 reference

1 reference

1 reference

2

1 reference

17 November 2017

A S Strimpakos

1

1 reference

17 November 2017

C Mikropoulos

3

1 reference

17 November 2017

I Petkar

4

1 reference

17 November 2017

Y Barbachano

5

1 reference

17 November 2017

I Chau

6

1 reference

17 November 2017

27 October 2009

1 reference

17 November 2017

1 reference

17 November 2017

21

1 reference

17 November 2017

5

1 reference

17 November 2017

1013-1019

1 reference

Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer

17 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP449

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP449

Chemotherapy-induced carcinoembryonic antigen surge in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP449

Transient CEA increase at start of oxaliplatin combination therapy for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP449

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP449

Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP449

Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP449

Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP449

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP449

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP449

Carcinoembryonic antigen gene family: molecular biology and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP449

Carcinoembryonic antigen as a selective enhancer of colorectal cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP449

Colonic Tumor CEA, CSAp and MUC-1 Expression following Radioimmunotherapy or Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP449

Increased expression of CEA and MHC class I in colorectal cancer cell lines exposed to chemotherapy drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP449

Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP449

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDP449

1 reference

17 November 2017

1 reference